Chester County News and Community Website
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has cemented a collaboration with renowned cell therapy leaders Professors Georg Schett and Andreas Mackensen to initiate a Phase 1/2 trial exploring its …
Century Therapeutics Partners with Experts for New Trial on Autoimmune Diseases Read More PHILADELPHIA, PA — Century Therapeutics (NASDAQ: IPSC) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference, scheduled for Wednesday, December 4, 2024. Members of the company’s leadership …
Century Therapeutics to Present at Piper Sandler 36th Annual Healthcare Conference Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced its financial results and business updates for the third quarter of 2024, highlighting significant progress in its clinical trials and …
Century Therapeutics Expands Clinical Focus and Reports Steady Financials for Q3 2024 Read More PHILADELPHIA, PA — Century Therapeutics (NASDAQ: IPSC) is set to showcase groundbreaking advancements in its iPSC-derived cell therapy platform at the upcoming 2024 ASH Annual Meeting in San Diego, from …
Century Therapeutics to Present Cutting-Edge Preclinical Data at 2024 ASH Annual Meeting Read More PHILADELPHIA, PA — Century Therapeutics (NASDAQ: IPSC) announced that Brent Pfeiffenberger, Pharm.D., CEO, and Chad Cowan, Ph.D., Chief Scientific Officer, will join a fireside chat at Guggenheim’s Inaugural Healthcare Innovation …
Join Century Therapeutics at Guggenheim’s Healthcare Innovation Conference! Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced key leadership changes with the appointments of Morgan Conn, Ph.D., as Chief Financial Officer and Chad Cowan, Ph.D., as Chief …
Century Therapeutics Announces Strategic Leadership Appointments Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced its financial results for the second quarter ending June 30, 2024, along with key business updates.
Century Therapeutics Reports Q2 2024 Financial Results and Business Highlights Read More PHILADELPHIA, PA — Emerging from the recent ASGCT 27th Annual Meeting, Century Therapeutics (NASDAQ: IPSC) has caught the attention of the medical world. The company revealed its innovative Allo-Evasion™ platform, …
Revolutionary Leap in Biotherapy: Century Therapeutics’ Ground-Breaking Technology Proves Promising Read More PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC), a pioneer in developing induced pluripotent stem cell (iPSC) derived therapies, shared a promising update on its financial standing and strategic advancements …
Century Therapeutics Announces Expansion and Significant Progress in Autoimmune and Cancer Therapies Read More